Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.

Brain

INSERM U1169/MIRCen CEA 92265 Fontenay aux Roses and Université Paris-Sud, Université Paris Saclay, 91400 Orsay, France.

Published: July 2017

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awx109DOI Listing

Publication Analysis

Top Keywords

reply beneficial
4
beneficial interleukin-2-based
4
interleukin-2-based immunomodulation
4
immunomodulation alzheimer-like
4
alzheimer-like pathology
4
reply
1
interleukin-2-based
1
immunomodulation
1
alzheimer-like
1
pathology
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!